Skip to content

Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases

Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07383844
Acronym
Feels-Mici
Enrollment
60
Registered
2026-02-03
Start date
2026-01-21
Completion date
2027-01-31
Last updated
2026-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)

Keywords

physical activity

Brief summary

This study aims to identify perceived barriers and facilitators to regular physical activity among children and adolescents with inflammatory bowel disease (IBD) followed in pediatric gastroenterology. Approximately 60 participants aged 10-17 years will complete two self-administered questionnaires (CAPAS-Q for physical activity/sedentary behavior and IMPACT-III for health-related quality of life) and take part in a single semi-structured interview exploring experiences, obstacles, and levers to support sustainable physical activity. Relevant clinical data (disease characteristics, treatment and selected routine clinical parameters) will be extracted from the medical record. Participation is limited to one visit (about 45-60 minutes) during a routine hospital appointment, with no additional intervention or follow-up required.

Interventions

OTHERData collection: CAPAS-Q

Participants complete the self-administered questionnaires CAPAS-Q.

OTHERIMPACT-III questionnaires

Participants complete the self-administered questionnaires IMPACT-III)

OTHERsemi-structured interview

participate in a semi-structured interview about perceived barriers and facilitators to physical activity. No counseling, training, or treatment is provided.

Sponsors

Fondation Lenval
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Aged 10 to 17 years at inclusion. * Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months. * Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice). * Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview. * Affiliated to, or beneficiary of, a social security scheme. * no parental objection to participation (non-opposition).

Exclusion criteria

* Younger than 10 years or older than 17 years. * No IBD diagnosis, or IBD diagnosed less than 6 months ago. * Associated chronic condition (neurological, metabolic, psychiatric, or other) likely to interfere with questionnaire completion or interview participation. * Major language or cognitive impairment preventing adequate understanding or interview participation. * Not affiliated to, or not beneficiary of, a social security scheme.

Design outcomes

Primary

MeasureTime frameDescription
Perceived barriers and facilitators to regular physical activityat the inclusionAssessed through a single semi-structured interview. Qualitative thematic analysis will be used to identify and categorize perceived barriers and facilitators to regular physical activity in pediatric IBD.

Secondary

MeasureTime frameDescription
Physical activity level and sedentary behavior (CAPAS-Q)at the inclusionMeasured using the CAPAS-Q self-administered questionnaire to describe participants' physical activity and sedentary behavior.
Health-related quality of life (IMPACT-III)at the inclusionMeasured using the IMPACT-III self-administered questionnaire to assess health-related quality of life in pediatric IBD.

Countries

France

Contacts

CONTACTALINE JOULIE
joulie.a@chu-nice.fr0492030520
CONTACTOlivier Courbette
olivier.courbette@hpu.lenval.com+33.4.92.03.05.65

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026